We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Acquires Biopharmaceutical Company for $454 Million
GSK Acquires Biopharmaceutical Company for $454 Million
December 8, 2006
GlaxoSmithKline (GSK) will acquire biopharmaceutical company Domantis for $454 million in cash, GSK announced.